Building the Future of Pharma with Insight and Innovation
Ofobid-200™ (Ofloxacin Tablets IP 200 mg)
Ofobid-200™ is a fluoroquinolone antibiotic containing Ofloxacin 200 mg, used to treat a wide range of bacterial infections affecting the urinary tract, respiratory tract, and gastrointestinal system.
Ofobid-200™ Tablets contain Ofloxacin IP 200 mg, a broad-spectrum fluoroquinolone antibiotic that works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial replication and survival.
It is commonly prescribed for the treatment of urinary tract infections, respiratory tract infections, gastrointestinal infections, sexually transmitted infections, and skin and soft tissue infections caused by susceptible bacteria. Ofloxacin offers good oral absorption and effective tissue penetration, ensuring reliable clinical outcomes.
Ofobid-200™ should be taken strictly as prescribed by a healthcare professional. Completing the full course of therapy is essential to ensure complete eradication of infection and to reduce the risk of antibiotic resistance.
